Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohl T Kinning

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood Advances|March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulationL Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Nature Genetics|June 5, 2023
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelKatherine A Waugh, Ross Minter, Jessica Baxter, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood Advances|March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulationL Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Nature Genetics|June 5, 2023
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelKatherine A Waugh, Ross Minter, Jessica Baxter, et al.
Pageof 1